En Es
Categories

Industry News


Greiner Bio-One lanza un soporte de tubos para la recolección de sangre

By Labmedica en español staff writers
26 Dec 2018

Imagen: El soporte de tubos Vacuette Safelink (Fotografía cortesía de Greiner Bio-One).Greiner Bio One International (Kremsmünster, Oberösterreich, Austria) lanzó el soporte novedoso para tubos VACUETTE SAFELINK, con luer lock masculino, que facilita la extracción de sangre de forma rápida y sencilla. El tubo ofrece un manejo sencillo y se puede utilizar en combinación con todos los productos médicos que tienen una conexión de bloqueo luer hembra estándar, como las cánulas aladas.

Greiner Bio-One desarrolla sistemas de recolección para muestras humanas y veterinarias que hacen que el flujo de tareas cotidianas en hospitales, laboratorios o consultas médicas sea más sencillo y seguro. La compañía ofrece productos de recolección de muestras hechos de plástico y también brinda soluciones a la medida. La línea de productos VACUETTE de Greiner Bio-One se utiliza en hospitales, laboratorios, consultorios médicos y centros de donantes de sangre en más de 100 países de todo el mundo.

La compañía ahora ha agregado el soporte para tubos VACUETTE SAFELINK a su línea de productos que viene con una función de cierre luer, lo que lo distingue de los soportes para tubos Greiner Bio-One convencionales y lo hace especialmente adecuado para la extracción de sangre usando dispositivos de acceso venoso según las recomendaciones de la guía (Estándar de práctica de terapia de infusión, revisado 2016).

Además, VACUETTE SAFELINK, que se fabrica con plástico irrompible y no contiene látex de caucho natural, ofrece una conexión de tornillo segura entre el soporte y el producto de recolección para garantizar una recolección de sangre segura y exitosa. Con un movimiento de roscado controlado, el producto, de un solo uso, se conecta de forma segura y sin problemas al dispositivo médico correspondiente. Las pruebas han demostrado que la conexión segura puede soportar presiones de hasta 185 mmHg, que combinadas con su diseño funcional y manejo práctico, podrían contribuir significativamente a una mayor eficiencia en situaciones de atención médica cotidiana.

Enlace relacionado:
Greiner Bio One International GmbH
Infusion Nurses Society




E-mail Print
FaceBook Twitter Google+ Linked in

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, laboratories and blood banks. The Bioscience division manufactures products for the biomedical industry, including pipettes, PCR plates, reaction tubes, analyzer cups, and cell separation media
Gold member
More info

More articles about Greiner Bio-One

18 Dec 2018
Greiner Bio-One Launches Tube Holder for Blood Collection
Greiner Bio One International has launched the innovative VACUETTE SAFELINK tube holder with male luer lock that facilitates quick and easy blood collection. The tube offers simple handling and can be used in combination with all medical products that have a standard female luer lock connection, such as winged cannulae.
Read More
25 Jun 2018
Greiner Bio-One Launches New Safety Blood Collection Set
Greiner Bio-One has made a new addition to its range of safety products and now offers its customers an even wider selection of safety blood collection sets with the launch of the VACUETTE SAFETY Winged Set.
Read More
28 Mar 2017
Greiner Bio-One to Serve Spain and Portugal through Distribution Subsidiaries
Greiner Bio-One has acquired its long-standing distribution partners, VacuetteEspaña and Vacuette Portugal, which will now allow the medical technology company to serve its customers in Spain and Portugal directly through its own distribution subsidiaries.
Read More

Additional news

25 Nov 2021
Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases
The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic cases, technological developments in point of care devices and increased investments by the key players.
Read More
24 Nov 2021
Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany
The XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021) to be held as an in-presence meeting between 28th of November and 2nd of December in Germany has been postponed as the country has been hit very hard by a fourth wave of COVID-19.
Read More
19 Nov 2021
44th World Hospital Congress (WHC) Ends on Upbeat Note as Hospital Leaders Look to Build Resilience
The 44th World Hospital Congress (WHC) organized by The International Hospital Federation (IHF; Geneva, Switzerland) on 8-11 November 2021 in Barcelona, Spain came to an upbeat close.
Read More
16 Nov 2021
Deborah Bowen (USA) Takes Up Position of IHF President for 2021-2023
Deborah Bowen has taken up the position of President of the International Hospital Federation (IHF; Geneva, Switzerland) following her election in 2019 and a two-year term as President Designate.
Read More
16 Nov 2021
IHF and Deloitte Collaborate to Launch Special Interest Group on Leadership for Sustainability
The International Hospital Federation (IHF; Geneva, Switzerland) will collaborate with Deloitte (London, UK) to launch a special interest group (SIG) centered around leadership for sustainability.
Read More
16 Nov 2021
International Hospital Federation (IHF) Announces Winners of IHF Awards 2021
The International Hospital Federation (IHF; Geneva, Switzerland) announced the winners of the IHF Awards 2021 as part of a special ceremony at the 44th World Hospital Congress (WHC) held in Barcelona, Spain.
Read More
13 Nov 2021
GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health
General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023.
Read More
11 Nov 2021
Blood Borne Testing Market to Witness Exponential Growth Due to Rising Incidence of Bacterial Infections
The global blood borne testing market is projected to record an exponential CAGR of over 7-8% during 2021-2031, driven by increasing bacterial infection and growing adoption of point of care devices, aided further by technological advancement in devices for blood borne pathogens. These are the latest findings of Fact.MR (Dublin, Ireland), a market research firm.
Read More
10 Nov 2021
AI in Radiology Market Driven by Growing Adoption of Machine Learning Tools in Broad Spectrum of Imaging Applications
The use of AI algorithms in medical image analysis field has made astounding progress. Particularly deep learning has made incessant inroads in radiology practice. The major consumer proposition for companies in the AI in radiology market stems from the exceptional capabilities of AI tools in recognizing complex patterns in the imaging data. These are the latest findings of Transparency Market Research (Albany NY, USA).
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions